Zhitong Finance App News, Tong Ren Tang (600085.SH) issued an announcement. Recently, Beijing Tongrentang Sinopharm Co., Ltd. (hereinafter referred to as Tongrentang Sinopharm), the company's holding company, received the “Certificate of Registration for Proprietary Chinese Medicine” issued by the Hong Kong Traditional Chinese Medicine Administration, permitting the sale of “Angelica Blood Supplement Granules [Tong Ren Tang]” in Hong Kong.
According to the announcement, after receiving the registration certificate for proprietary Chinese medicines issued by the Hong Kong Traditional Chinese Medicine Administration, Tongrentang Sinopharm's angelica blood supplement granules “Tong Ren Tang” can be sold in Hong Kong, which will help enrich its product line and facilitate its market expansion. The acquisition of the above registration certificate will not have a significant impact on the company's production, operation and performance for the time being.